C反应蛋白、S100B蛋白和神经元特异性烯醇化酶水平与小儿癫痫之间的相关性分析

目的探究癫痫患儿血清及脑脊液中S100B蛋白、神经元特异性烯醇化酶(NSE)和C反应蛋白(CRP)水平与小儿癫痫发作之间的关联性。方法选取2016年6月至2017年8月该院住院治疗的癫痫患儿35例(癫痫组)及同期体检健康儿童50例(对照组)作为研究对象。癫痫组患儿癫痫发作后第1、3、7天分别采用酶联免疫吸附法(ELISA)、化学发光法、免疫比浊法检测其血清及脑脊液中S100B蛋白、NSE、和CRP水平并与对照组进行分析比较。结果癫痫组患儿癫痫发作后第1、3天血清及脑脊液中S100B蛋白、NSE及CRP水平均明显高于对照组,差异有统计学意义(P0.05);而癫痫组发作后第7天血清及脑脊液中S100B蛋白、NSE及CRP水平与对照组比较,差异无统计学意义(P0.05)。结论癫痫病患儿血清及脑脊液中S100B蛋白、NSE及CRP水平异常升高与神经细胞过度凋亡密切相关,血清及脑脊液中S100B蛋白、NSE和CRP水平有望成为小儿癫痫发作的特异性生化预测指标。     

左乙拉西坦联合地西泮治疗热惊厥患儿临床疗效研究

[目的]探讨左乙拉西坦联合地西淖治疗热惊厥患儿疗效及对血清Zeste基因增强子同源物2(EZH2)、神经元特异性烯醇化酶(NSE).S100B.神经元特异性生长因子(BDNF)水平的影响。[方法]选取2018年1月至2019年12月本院收治的100例热惊厥患儿(观察组),并选择同期门诊健康体检的100例儿童作为对照组,根据治疗方法的不同将观察组患儿分为A组(采用地西泮治疗)和B组(左乙拉西坦联合地西泮治疗),各50例。比较不同组别血清EZH2.NSE.S100β、BDNF水平.比较两组临床疗效及相关指标的变化。[结果]观察组血清EZH2.NSE.S100p.BDNF水平均高于对照组,差异有统计学意义(P<0.05)。A组患儿.药物起效时间、惊厥停止时间分别为(21.60±3.95)min.(24.51±4.06)min,B组分别为(17.53±3.04)min、(20.48±3.77)min,两组比较差异均有统计学意义(均P<0.05)。治疗后,B组患儿血清EZH2、NSE.S100β水平均低于对照组,差异均有统计学意义(均P<0.05)。B组患儿临床有效率为96%(48/50).高于A组患儿的92%(42/50),差异有统计学意义(Z=-2.198,P=0.028<0.05)。[结论]热惊厥患儿血清EZH2、NSE.S100p、BDNF水平明显高于较健康儿童,左乙拉西坦联合地西泮治疗热惊厥患儿效果优于单用地西泮。     

轻度胃肠炎伴婴幼儿良性惊厥患儿细胞炎症因子、免疫水平及脑脊液中髓鞘碱性蛋白、神经元特异性烯醇化酶水平变化与临床意义

目的探讨轻度胃肠炎伴婴幼儿良性惊厥(BICE)患儿细胞炎症因子、免疫水平及脑脊液中髓鞘碱性蛋白(MBP)、神经元特异性烯醇化酶(NSE)水平的变化与临床意义。方法选取42例BICE患儿为观察组,并将观察组患儿按照发生惊厥次数分为A、B组,A组18例患儿为惊厥发生2次,B组24例为惊厥发生≥2次,同期选取42例轻度胃肠炎但不伴有惊厥发作患儿为对照组。观察各组患儿细胞炎症因子、免疫水平及脑脊液中MBP、NSE水平。结果观察组患儿肿瘤坏死因子-α(TNF-α)、干扰素-γ(INF-γ)、白细胞介素-6(IL-6)水平高于对照组,CD3~+、CD4~+及CD4~+/CD8~+水平低于对照组,差异有统计学意义(P 0.05)。观察B组患儿TNF-α、IL-6、INF-γ水平高于观察A组,CD3~+、CD4~+及CD4~+/CD8~+水平低于观察A组,差异有统计学意义(P 0.05);观察B组患儿脑脊液S-100β蛋白(S-100β)、NSE水平高于观察A组,差异有统计学意义(P 0.05)。结论在BICE患儿发生惊厥过程中,观察其细胞炎症因子、免疫水平及脑脊液中MBP、NSE水平的变化具有重要临床价值,可了解患儿的身体状况,有利于筛查高风险患儿和制定相关防治措施。     

白细胞介素6和神经元特异性烯醇化酶在惊厥性脑损伤中的临床价值

目的 探讨惊厥性脑损伤患儿血清、脑脊液白细胞介素6(interleukin-6,IL-6)和神经元特异性烯醇化酶(neuron-specific enolase,NSE)水平变化的临床价值.方法 观察惊厥患儿100例,据病情分为惊厥持续状态组38例、多次惊厥组32例,单次惊厥组30例,选择同期无惊厥患儿30例为对照组,测定患儿惊厥发作后24、72小时血清、脑脊液IL-6、NSE的水平变化.结果 惊厥发作后24小时各惊厥组血清、脑脊液中IL-6、NSE均明显高于对照组,差异有统计学意义(P＜0.05);惊厥持续状态组明显高于多次惊厥组,多次惊厥组明显高于单次惊厥组,差异均有统计学意义(P＜0.05).72小时后各惊厥组IL-6、NSE与24小时比较均明显降低,差异有统计学意义(P＜0.05).相关分析示,血清IL-6与NSE呈正相关(P＜0.05),脑脊液IL-6与NSE呈正相关(P＜0.05),血清、脑脊液IL-6呈正相关(P＜0.05);血清、脑脊液NSE呈正相关(P＜0.05).结论 IL-6与NSE参与了惊厥性脑损伤的病理损害过程,能反映惊厥性脑损伤病理损害的严重程度,评估惊厥惠儿预后.     

血清S100B蛋白测定对儿童自身免疫性脑炎早期识别的临床意义

目的 探讨血清S100B蛋白测定对儿童自身免疫性脑炎（AE）早期识别的临床意义。方法 选取30例AE患儿为AE组、30例病毒性脑炎患儿为病毒性脑炎组、30名健康儿童为健康对照组，分别检测3组的血清S100B蛋白、神经元特异性烯醇化酶（NSE）、基质金属蛋白酶（MMP）水平，使用受试者操作特征（ROC）曲线分析血清S100B蛋白、NSE、MMP水平对儿童AE早期识别的预测价值。比较不同分期、不同病情程度和不同预后AE患儿的血清S100B蛋白水平。结果 AE组的血清S100B蛋白、NSE、MMP水平高于病毒性脑炎组、健康对照组，且病毒性脑炎组的血清S100B蛋白、NSE、MMP水平高于健康对照组（P <0.05）。血清S100B蛋白、NSE、MMP水平预测AE时，血清S100B蛋白的AUC最高，为0.881，明显高于NSE(Z=2.142,P=0.032)和MMP(Z=2.360,P=0.018)。急性发作期、重症、预后不良的AE患儿血清S100B蛋白水平分别高于恢复期、轻症、预后良好的AE患儿（P <0.05）。结论 血清S100B蛋白测定对儿童AE的早期诊断有较高价值，且S...     

惊厥患儿血清神经元特异性烯醇化酶水平变化及临床意义

惊厥是儿科主要的急症之一,通过某种特异性生化指标评价惊厥患儿脑损伤程度、预后是临床迫切需要解决的问题。有研究表明：神经元特异性烯醇化酶（neuronpeclficenolase,NSE）可作为脑内神经元损伤的指标[1],本研究检测了自1998年10月～1999年4月80例惊厥患儿血清NSE水平变化,以探讨NSE在判断惊厥患儿脑损伤的程度及预后中的临床价值。回材料和方法1.1临床资料1．1．1癫痫持续状态患儿12例患儿全部全身性惊厥性癫痛持续状态（generalconvulsivestatuseelleetlcs,GCSE）。符合国际诊断标准,30min以上明显的症状性或持发性抽搐发…     

癫痫患儿血清α-突触核蛋白和热休克蛋白70的表达及临床意义

目的探讨癫痫患儿血清α-突触核蛋白(α-Syn)、热休克蛋白70(HSP70)的变化,分析二者与认知功能、事件相关电位、血清炎症细胞因子的关系。方法选取该院2016年8月至2019年8月收治的癫痫患儿105例作为癫痫组,根据癫痫类型进一步分为癫痫1组(癫痫频发)、癫痫2组(癫痫持续状态)、癫痫3组(非频发非持续状态)。另选取同期体检的健康儿童68例为健康对照组。检测并比较各组血清α-Syn、HSP70、白细胞介素-1β(IL-1β)、白细胞介素-6(IL-6)、C反应蛋白(CRP)、肿瘤坏死因子-α(TNF-α)水平。观察各组中国韦氏儿童智力量表(C-WISC)评分及事件相关电位P300。分析血清α-Syn、HSP70水平与认知功能、事件相关电位P300潜伏期、炎症因子的相关性。结果癫痫组血清α-Syn、HSP70、IL-1β、IL-6、CRP、TNF-α水平高于健康对照组,P300潜伏期较健康对照组延长,而C-WISC评分低于健康对照组,差异有统计学意义(P0.05)。癫痫1组、癫痫2组的血清α-Syn、HSP70、IL-1β、IL-6、CRP、TNF-α水平均高于癫痫3组,且P300潜伏期长于癫痫3组,而癫痫1组、癫痫2组的C-WISC评分低于癫痫3组,差异有统计学意义(P0.05)。Pearson线性相关分析显示,血清α-Syn、HSP70水平与C-WISC评分呈负相关,而与P300潜伏期及血清IL-1β、IL-6、CRP、TNF-α水平呈正相关(P0.05)。结论与健康儿童相比,癫痫患儿血清α-Syn、HSP70水平明显增高,二者水平变化与认知功能、P300潜伏期及机体炎症密切相关。     

14例儿童非惊厥性癫痫持续状态的护理

目的 本文通过对非惊厥性癫痫持续状态的患儿进行急救护理,总结了非惊厥性癫痫持续状态的护理体会.方法 对10年间14例非惊厥性癫痫持续状态的患儿实施全面的护理,并对护理结果进行评估.结果 系统性整体护理下非惊厥性癫痫持续状态患儿的抢救成功率95%以上,无1例发展为惊厥性癫痫持续状态.结论 系统全面的有效护理可以提高病人的抢救成功率及患儿康复效果,提高患儿生存质量.     

儿童病毒性脑炎脑脊液肿瘤坏死因子和神经元特异性烯醇化酶的变化

目的:观察儿童病毒性脑炎脑脊液肿瘤坏死因子(TNF-α)和神经元特异性烯醇化酶(NSE)的变化,以探讨其在儿童病毒性脑炎的临床意义。方法:用放射免疫分析法和电化学发光法测定38例儿童病毒性脑炎急性期脑脊液TNF-α和NSE质量浓度,并对其中18例恢复期患儿进行复查。以非颅内感染患儿20例作为对照组。结果:(1)儿童病毒性脑炎急性期脑脊液TNF-α和NSE质量浓度为(22.65± 15.58)ng/mL和(16.05± 10.89)ng/mL,显著高于对照组(2.38± 1.55)ng/mL(P<0.01)和(8.23± 3.26)ng/mL(P<0.05)。病毒性脑炎恢复期脑脊液TNF-α质量浓度为(7.89± 3.22)ng/mL,显著低于急性期(P<0.05);而NSE质量浓度为(11.36± 4.55)ng/mL,下降不明显(P>0.05)。(2)病毒性脑炎急性期脑脊液TNF-α和NSE呈明显的正相关(r=0.368,P<0.05)。结论:TNF-α和NSE的变化反映了儿童病毒性脑炎时炎症反应、脑损伤的严重程度,且脑损伤的恢复是一个缓慢的过程;脑脊液TNF-α和NSE的检测有助于判断儿童病毒性脑炎的病情和脑损伤程度,可作为早期诊断参考指标,观察其动态变化有助于指导治疗和判断预后。     

右美托咪啶对老年脑肿瘤患者开颅手术后脑保护机制的研究

目的:探讨右美托咪啶(DEX)对老年脑肿瘤患者开颅手术后脑损伤的保护机制。方法:60例行脑肿瘤手术切除的老年患者随机分成DEX组和对照组各30例,DEX组术前静脉输注DEX,对照组术前给予生理盐水。分别于诱导前(T1)、切开硬脑膜(T5)、取瘤(T6)、术毕(T7)、术后24 h(T8)采集血液标本,检测血清S100β、神经元特异性烯醇化酶(NSE)、白介素6(IL-6)、肿瘤坏死因子-α(TNF-α)、超氧化物歧化酶(SOD)水平。结果:在T1、T5时点,患者血清中的S100β、NSE蛋白浓度水平差异无统计学意义(P0.05),在T6~T8时点,DEX组血清中的S100β、NSE蛋白水平低于对照组(P0.05)。在T1时点,2组血清IL-6、TNF-α蛋白水平和SOD活性差异无统计学意义(P0.05),在T5~T8时点,DEX组血清IL-6、TNF-α蛋白水平低于对照组(P0.05),DEX组SOD活性水平高于对照组(P0.05)。结论:DEX对老年脑肿瘤患者手术切除脑损伤的保护机制可能是有效降低血清中S100β、NSE、TNF-α、IL-6浓度,减缓SOD活性水平的下降。     

Dex术中应用对老年胃癌根治术患者血清S100B、NSE及炎性指标的影响

[目的]探讨全麻下老年胃癌根治术中右美托咪定(Dex)的应用对患者血清S100B蛋白(S100B)、神经元特异性烯醇化酶(NSE)及炎性指标的影响.[方法]选取本院在同一组医护人员管理下拟实施腹腔镜胃癌根治术的患者96例作为研究对象,依据就诊顺序随机分为Dex组、对照组各48例.两组均采用气管插管下静脉全麻,Dex组同...     

大黄素联合康复训练改善脑梗死大鼠炎症损伤和神经功能损伤

目的 探究大黄素联合康复训练对脑梗死大鼠炎症损伤和神经损伤的改善作用。方法 清洁级SD大鼠96只,雌雄各半,鼠龄2～3月,体重200～260 g,由武汉大学动物实验中心提供。按随机数字表分为假手术组、模型组、康复训练组、大黄素+康复训练组,每组各24只。对模型组、康复训练组、大黄素+康复训练组的大鼠采用线栓法制备大脑中动脉栓塞的脑缺血模型,假手术组仅进行颈部血管暴露处理。其中假手术组和模型组进行常规饲养,康复训练组进行转棒训练、网屏训练、跑台训练等训练,大黄素+康复训练组在康复训练组的基础上,联用大黄素进行治疗。在术后第21天,比较各组大鼠神经功能评分;比较细胞色素C(CytC)、Bax、Caspase-3、神经元特异性烯醇化酶(NSE)、S100B等指标含量;比较大鼠缺血侧海马组织中白细胞介素(IL)-6、IL-1β、肿瘤坏死因子-α(TNF-α)的水平;比较大鼠缺血侧海马组织中NF-κB p65和IκBα蛋白表达水平。结果 假手术组大鼠未发现神经功能缺损的症状,经干预后,模型组、康复训练组、大黄素+康复训练组的神经功能评分均随时间延长有所降低,其中模型组的变化最小;与模型组比较,康...     

高压氧联合常规疗法在病毒性脑炎患者中的应用价值

【目的】探讨高压氧（HBO）联合常规疗法综合治疗病毒性脑炎的疗效及对肿瘤坏死因子α（TNF-α）、神经元特异性烯醇化酶（NSE）、S100b蛋白、白介素-6（IL-6）、C-反应蛋白（CRP）水平的影响。【方法】选择病毒性脑炎惠儿125例,按照入院的先后顺序分为两组,对照组63例,采用常规治疗,观察组62例,采用高压氧＋常规治疗法,比较两组疗效及TNF-α、NSE、S100b蛋白、IL-6、CRP水平。【结果】观察组的总有效率为96．8％,显著高于对照组的74．6％（P〈0．05）;两组患儿的TNF-α、IL-6、NSE、S100b蛋白和CRP水平均随治疗逐渐下降,观察组下降显著低于对照组（P〈O．05）,IL-6值显著高于对照组（P〈0．05）。【结论】高压氧联合常规疗法综合治疗病毒性脑炎疗效安全、有效,值得临床推广应用。     

Elevated serum S100B protein and neuron-specific enolase levels in carbon monoxide poisoning

Objective

Carbon monoxide (CO) poisoning causes cerebral and generalized hypoxia. This study aimed to assess the possible use of serum glial marker S100B protein and neuron-specific enolase (NSE) as biochemical markers of hypoxic brain damage in acute CO poisoning.

Methods

Patients with acute CO poisoning admitted to the ED of 2 training hospitals (Ankara, Turkey) were included in this cross-sectional study. Serum levels of S100B and NSE were measured on admission. The patients were divided into 2 groups (unconscious and conscious). Twenty healthy adults were included in the study to serve as controls.

Results

A total of 70 patients poisoned by CO (mean age ± SD, 36.6 ± 16.3 years; 64.3% women) were enrolled. Although S100B concentrations were higher in patients than in the control group (P = .018), no significant difference was determined between patient and control groups with respect to NSE concentrations (P = .801). A positive correlation was noted between levels of S100B and NSE (r = 0.388; P = .001). The S100B and NSE values were higher in unconscious patients than in the control group (P = .002 and P = .013, respectively). Furthermore, S100B and NSE values were higher in unconscious vs unconscious patients (P = .047 and P = .005, respectively).

Conclusion

Elevated serum S100B and NSE levels were associated with loss of consciousness in CO poisoning in this series of patients. Serum S100B and NSE may be useful markers in the assessment of clinical status in CO poisoning.     

Increased serum S-100B and neuron specific enolase - Potential markers of early nervous system involvement in essential hypertension

ObjectivesTo investigate the occurrence of subclinical neurologic involvement in patients with essential hypertension employing serum biochemical markers.Design and methodsFifty patients with essential hypertension and 42 controls with no clinical evidence of neurological disease were recruited. Serum S100B protein and neuron specific enolase (NSE) were determined by employing immunoassay kits from CanAg Diagnostics AB (Sweden). Brain MRI and fundoscopic exploration were conducted.ResultsS-100B and NSE levels were significantly higher in hypertensive patients than in controls. In hypertensive patients, multivariate analysis revealed that NSE was independently associated with two variables expressing severity of hypertension: diastolic blood pressure and grade of retinopathy. Brain MRI studies demonstrated higher NSE levels in patients with more severe white matter lesions.ConclusionsRaised NSE levels are associated with a higher severity of hypertension and of white matter lesions, providing preliminary evidence that suggests the presence of silent brain damage in a subset of hypertensive patients.     

S100B蛋白、NSE与HIE患儿病情严重程度及神经行为功能相关性分析

目的探讨血清S100B蛋白、神经元特异性烯醇化酶(NSE)与新生儿缺氧缺血性脑病(HIE)的相关性。方法选取68例HIE患儿,根据病情分为重度HIE组(20例)、中度HIE组(25例)和轻度HIE组(23例)。以25名健康新生儿作为正常对照组。检测所有对象血清S100B蛋白、NSE水平,并进行新生儿神经行为(NBNA)评分,计算NBNA评分异常率。动态观察HIE患儿出生后24 h、48 h、72 h、7 d的血清NSE及S100B蛋白的变化。结果正常对照组、轻度HIE组、中度HIE组、重度HIE组S100B蛋白、NSE水平及NBNA评分异常率依次升高,NBNA评分依次降低,各组间差异均有统计学意义(P<0.001)。血清S100蛋白、NSE水平与NBNA评分呈负相关(r值分别为-0.243、-0.542,P<0.001),与HIE严重程度呈正相关(r值分别为0.398、0.476,P<0.001)。随着出生时间的延长,重度HIE组、中度HIE组、轻度HIE组血清S100B蛋白和NSE水平均逐渐降低(P<0.001)。轻度HIE组、中度HIE组、重度HIE组同一时间点血清S100B蛋白和NSE水平均依次升高(P<0.001)。结论血清S100B蛋白、NSE水平与HIE病情严重程度、患儿神经行为有关,或可用于HIE的早期诊断和预后评估。     

S100B and NSE serum concentrations in Machado Joseph disease

BACKGROUND: NSE and S100B are considered as neuronal and glial peripheral markers of central nervous system pathologies, respectively. We evaluated the potential use of S100B and NSE serum concentrations as peripheral markers of symptomatic patients with Machado Joseph disease (MJD). METHODS: We measured S100B and NSE peripheral concentrations of 22 MJD patients and compared with healthy subjects concentrations. The correlations of both markers with CAG repeat size, age of onset, disease duration, and the scores of the Extended Disability Status Scale of Kurtzke, Unified Parkinson's Disease Rating Scale, and the Montgomery-Asberg depression rating scale were also assessed. RESULTS: S100B serum concentrations between control and MJD subjects were not statistically different, whereas NSE serum concentrations were higher in MJD patients than in control subjects (p=0.00001). S100B presented a moderate correlation with disease duration and depression score, whereas NSE presented a moderate correlation with depression score and a good negative correlation with EDSS score. CONCLUSIONS: Symptomatic MJD patients present increased concentrations of NSE and normal concentrations of S100B in blood.     

The Modified Glasgow Outcome Score for the prediction of outcome in patients after cardiac arrest: a prospective clinical proof of concept study

The Glasgow-Pittsburgh cerebral performance categories (GP-CPC) and the Glasgow Outcome Score (GOS) have been used to categorize patients according to their neurological outcome for prognostic predictors in patients after cardiac arrest (CA). We postulated that inclusion of deaths without knowing the cerebral status into the group of patients with poor outcome after CA using the GP-CPC and GOS will lead to dilution of the prognostic power of the investigated biochemical marker. The present study was conducted to verify this issue by employing a modified outcome score, which we termed as Modified Glasgow Outcome Score (MGOS). In the present study, 97 patients were enrolled in a prospective manner. Serum NSE and S100B levels were measured daily for 7 days after admission to the intensive care unit. Neurological outcome was assessed by employing the GOS and MGOS after 6 months. By employing the GOS, 46 patients were categorized into the group of patients with poor outcome and 51 patients survived with good neurological outcome. Patients who died without certified brain damage or with unknown cerebral status after CA (n = 20) were separated from patients with poor outcome in the MGOS. The magnitude of NSE (S100B) elevation in patients with poor outcome categorized by the MGOS was approximately 1.7-fold (1.5) higher as compared with patients divided by the GOS. The mean calculated sensitivities and area under the curve values of NSE and S100B predicting poor outcome classified by the MGOS were significantly higher as compared with the GOS. Conclusively, inclusion of deaths without certified brain damage or with unknown cerebral status into the group of patients with poor outcome will lead to underestimation of the prognostic power of investigated biochemical markers such as NSE and S100B. The MGOS will help to avoid this bias.     

血清S100B和神经元特异性烯醇化酶在脑血管意外患者中的检测及其临床意义

目的:探讨急性脑血管病患者血清S100B和神经元特异性烯醇化酶(NSE)的变化及其临床意义。方法:用双抗体夹心ELISA法检测58例脑梗死患者、36例脑出血患者治疗前和治疗后及30名健康人血清S100B和NSE水平。结果:脑梗死和脑出血患者的血清S100B、NSE浓度均高于对照组(P<0.001),脑梗死和脑出血患者的血清S100B、NSE浓度治疗后均低于治疗前(P<0.001);治疗前、脑梗死组患者的血清S100B浓度低于脑出血组患者(P<0.001),而脑梗死组患者的血清NSE浓度高于脑出血组患者(P<0.001)。结论:血清S100B和NSE检测可作为诊断早期脑损伤严重程度的指标;联合检测血清S100B和NSE,对鉴别诊断出血性脑病和缺血性脑病以及评价预后具有一定的临床意义。     

血浆S100B蛋白在缺氧缺血性脑病新生儿的诊断评估

目的 探讨血浆S100B蛋白对缺氧缺血性脑病(hypoxic ischemic encephalopathy,HIE)新生儿脑损伤的临床意义.方法 选择54例临床诊断为HIE的新生儿在出生12 h时抽血检测S100B、神经元特异性烯醇化酶(neuron specific enolase,NSE)及脑型肌酸激酶同功酶(creatine kinaes BB isozyme,CK-BB),与47例非HIE的窒息新生儿和22例健康新生儿进行对照比较.评价敏感性和特异性,绘制ROC曲线,计算ROC曲线下面积.结果 出生12 h时HIE患儿血浆S100B、NSE和CK-BB阳性率显著高于窒息组和对照组(均P<0.01),S100B对HIE的敏感性为88.89%,特异性为82.61%,之和高于NSE及CK-BB.S100B的ROC曲线下面积最大(面积:0.950;95%可信区间0.918-0.983),临床诊断效能高于NSE及CK-BB.结论 HIE患儿出生12 h时血浆S100B、NSE和CK-BB均能预示HIE患儿的脑部损伤,S100B阳性率最高,三指标联合检测,有助于HIE的早期诊断和病情判断.